If you void (urinate) more than eight times per day, you may be eligible to participate in this research study.
#1: A double-blind, randomized, parallel, placebo-controlled, multicenter study evaluating the effect of treatment with topically administered Oxybutyin Gel in patients with urinary frequency, and urge and mixed urinary incontinence with a predominance of urge incontinence episodes.
For additional information go to: www.antarespharma.com
Research Location:
Towson, MD
8322 Bellona Ave., Suite 202
Towson, MD 21204
Contact Debi Robertson, drobertson@cua.md or 410-825-6310 x163
#2: A 12-week, randomized, double-blind, placebo-controlled, parallel-group, multicenter trial to evaluate the efficacy and safety of Fesoterodine flexible dose regimen in vulnerable elderly patients with overactive bladder.
For additional information go to: www.pfizer.com
Research Locations:
Glen Burnie, MD
806 Landmark Dr., Suite 118
Glen Burnie, MD 21061
Contact Virginia Michaels, vmichaels@cua.md or 410-760-9400
Towson, MD
8322 Bellona Ave., Suite 202
Towson, MD 21204
Contact Debi Robertson, drobertson@cua.md or 410-825-6310 x163
|
 |
|
« Current Clinical Trials
|
|
|
|
Erectile Dysfunction (ED)
|
|
|
|
Enlarged Prostate: (Benign Prostatic Hyperplasia/BPH)
|
|
|
|
Bladder Cancer
|
|
|
|
Prostate Cancer
|
|
|
|
Overactive Bladder
|
|